Australian Pet Nutrition Immune Support: Veterinary Product Profile
- Entry kind
- Branded product
- Product family
- Australian Pet Nutrition Immune Support
Quick summary
Australian Pet Nutrition Immune Support is a named branded product for Dogs and cats; manufacturer positioning is kept separate from independent clinical and regulatory evidence.
What it is
100 g oral botanical and mushroom powder. Intended species: Dogs and cats.
Active ingredients / formula
The current official page lists Kakadu plum (Terminalia ferdinandiana), Reishi (Ganoderma lucidum), Maitake (Grifola frondosa), Turkey Tail (Trametes versicolor), Chaga (Inonotus obliquus), Cordyceps (Ophiocordyceps sinensis), olive leaf (Olea europaea), Echinacea (Echinacea purpurea), Elecampane (Inula helenium), and Astragalus (Astragalus membranaceus). Public quantitative amounts for each component are not provided on the reviewed page.
Mechanism / rationale
Australian Pet Nutrition markets Immune Support for general immune resilience, antioxidant, respiratory, digestive, energy, and recovery support in dogs and cats. The official page uses supportive rather than curative framing. The product should not be relabelled as a cancer treatment merely because it includes Turkey Tail and other mushrooms.
How it is discussed in tumor care
May be discussed only as supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.
Potential role
Define a modest supportive objective, baseline, review date, adverse-event plan, and stopping rule with the veterinarian.
Typical use context
Bring the current label, lot, full ingredient panel, country version, complete diet, medicines, and supplements to the treating veterinarian.
Evidence snapshot
The official manufacturer page verifies a current multi-ingredient powder, pack size, species, and named botanicals. No controlled canine or feline oncology trial of this finished formula was identified. Studies of one mushroom, vitamin-C-rich fruit, Echinacea, Astragalus, or another extract cannot demonstrate a tumour, treatment-tolerance, or survival outcome for this mixture.
Safety notes
The manufacturer cautions about use before anaesthesia or procedures and in pregnancy or lactation. This entry does not recreate a timing schedule. Review mushroom and plant allergy, immune-directed therapy, autoimmune disease, anticoagulant or antiplatelet medicines, diabetes, liver or kidney disease, gastrointestinal tolerance, and duplicate botanicals. Chaga and multi-herb products particularly warrant complete medicine review.
Interactions / cautions
No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.
Regulatory status
Marketed in Australia as a pet nutritional supplement. APVMA guidance distinguishes animal feeds without therapeutic claims from products making therapeutic claims. No APVMA registration as a veterinary cancer medicine was verified, and this profile does not assign one.
Regions, labels and market differences
Australia
Monitoring plan
Record the 100 g package, lot, full label, diet, medicines, procedure dates, and supportive goal. Track appetite, vomiting, diarrhoea, stool, itching, swelling, drinking, urination, energy, weight, bleeding or bruising, and treatment tolerance. Ask the veterinarian whether blood counts, chemistry, glucose, coagulation, or another measure is appropriate.
Questions to ask your veterinarian
- What exact supportive objective would justify considering Australian Pet Nutrition Immune Support?
- Does the current physical label match this identity, strength, and country version?
- Could an ingredient duplicate or interact with the existing medical, dietary, surgical, or oncology plan?
- Which adverse signs, tests, or treatment changes should trigger a pause?
- What review date, stopping rule, and objective tumour monitoring plan apply?